Products

View names, product characteristics and patient information for our products.

AbbVie Products List

 

You can find an A-Z list of our prescription medicines below as well as links to the relevant summary of product characteristics and patient information leaflets for each product. In compliance with regulations, we are unable to provide further information about our products on this website or any of our digital platforms. If you wish to report any side effects, please find a link to the MHRA listed at the bottom of the page.

Our products are approved and regulated in the UK by the European Medicines Agency (EMA) or the Medicines & Healthcare Products Regulations Agency (MHRA) for specific uses. Product availability, name and indicated use may vary by country and below an alphabetical list for the UK with links to the regulators information for prescribing healthcare professionals and patients.  

Not all products may be listed. This list may be updated at any time. Always ask a healthcare professional for advice about medicines.

 

Chirocaine (levobupivacaine hydrochloride) 

1.25mg/mlsolution for infusion

2.5mg/ml solution for injection/concentrate for solution  for  infusion

5mg/ml solution for injection/concentrate for solution for infusion

7.5mg/ml solution for injection/concentrate for solution for infusion  

 

            Duodopa (carbidopa monohydrate, levodopa)

20 mg/ml + 5mg/ml intestinal gel

            

Exviera▼(dasabuvir sodium monohydrate)

250 mg film-coated tablets

 

Humira (adalimumab)

80 mg/ 0.8 ml Pre-filled Syringe and Pre-filled Pen

40 mg/0.4 ml Pre-filled Syringe and Pre-filled Pen 

20 mg/ 0.2 ml Pre-filled Syringe

 

Isoflurane (inhalation anaesthetic)

 

Kaletra (lopinavir, ritonavir)

100mg/25mg film-coated tablets 

200 mg/50 mg film-coated tablets 

80mg/20mg Oral Solution 

 

Maviret ▼ (glecaprevir, pibrentasvir)

100 mg/40 mg film-coated tablets

 

Norvir (ritonavir)

100mg film-coated tablets 

Powder for Oral Suspension 100mg

 

Sevoflurane (sevoflurane)

 

Survanta (beractant)

25 mg/ml suspension

 

Synagis (palivizumab)

100 mg/ml solution for injection 

 

Venclyxto ▼(venetoclax)

10 mg, 50 mg and 100 mg film-coated tablets

 

Viekirax ▼(ombitasvir, paritaprevir, ritonavir)

12.5 mg/75 mg/ 50 mg film-coated tablets

 

Zemplar (paricalcitol)

1 microgram capsule, soft

2 micrograms capsule, soft 

5 microgram/ml Solution for Injection

 

If you believe you have experienced any medical side effects from an AbbVie UK product, please consult your physician, pharmacist or other healthcare professional immediately. Adverse events should always be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AbbVie UK on uk_pvvendor@abbvie.com


Additional note for medicines with a black triangle:

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.